Mucormycosis in the Eastern Mediterranean: A seasonal disease

Epidemiology and Infection

Volumn 134, Issue 2, 2006, Pages 341-346

  Al Ajam, Mohammad R ^a   Bizri, A R ^b   Mokhbat, J ^b,c,d   Weedon, J ^a   Lutwick, L ^e  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^c RIZK HOSPITAL   (Lebanon)

^d SAINT GEORGE HOSPITAL UNIVERSITY MEDICAL CENTER   (Lebanon)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CEFTAZIDIME; FLUCONAZOLE; IMIPENEM; KETOCONAZOLE; METRONIDAZOLE; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ADULT; AGED; AIR ANALYSIS; ARTICLE; AUTUMN; BRAIN INFECTION; CLINICAL ARTICLE; CLUSTER ANALYSIS; FEMALE; FUNGAL VIRULENCE; FUNGUS SPORE; HISTOPATHOLOGY; HUMAN; INCIDENCE; INFECTION RISK; LEBANON; LUNG INFECTION; MALE; MUCORALES; MUCORMYCOSIS; NONHUMAN; PARANASAL SINUSITIS; RISK ASSESSMENT; SEASONAL VARIATION; SKIN INFECTION; STATISTICAL SIGNIFICANCE; SUMMER; SYMPTOMATOLOGY; TIME SERIES ANALYSIS; WEATHER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DISEASE OUTBREAKS; FEMALE; HUMANS; INCIDENCE; ISRAEL; LEBANON; MALE; MEDITERRANEAN REGION; METEOROLOGICAL FACTORS; MIDDLE AGED; MUCORMYCOSIS; SEASONS;

EID: 33244460571     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268805004930     Document Type: Article

References (24)

1. Eucker J, Sezer O, Graf B, Possinger K. Mucormycosis. Mycoses 2000; 44: 253-260.
2. Meyers B, Gurtman A. Phycomycetes. In: Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious diseases, 2nd edn. Philadelphia: W. B. Saunders, 1998: 2382-2387.
3. Sugar A. Agents of Mucormycosis and related species. In: Mandell G, Bennette JE, Gordon Douglas R, Dolin R, eds. Principles and practice of infectious disease, 4th edn. New York: Churchill Livingstone, 1995: 2311-2321.
4. Blitzer A, Lawson W, Meyers BR, Biller HF. Patient survival factors in paranasal mucormycosis. Laryngoscope 1980; 90: 635-648.
5. Brown SR, Shah IA, Grinstead M. Rhinocerebral mucormycosis caused by Apophysomyces elegans. Am J Rhinol 1998; 12: 289-292.
6. Radner AB, Witt MD, Edwards Jr. JE. Acute invasive rhinocerebral mucormycosis in an otherwise healthy patient: Case report and review. Clin Infect Dis 1995; 20: 163-166.
7. Bhattacharyya AK, Deshpande AR, Nayak SR, Kirtane MV, Ingle MV, Vora IM. Rhinocerebral mucormycosis: An unusual case presentation. J Laryngol Otol 1992; 106: 48-49.
8. Quattrocolo G, Pignatta P, imanico U, Tarenzi L, Baggiore P. Rhinocerebral mucormycosis and internal carotid artery thrombosis in a previously healthy patient. Acta Neurol Belg 1990; 90: 20-26.
9. Trujillo J, Infante G, Galan S, Dominguez V. Seasonal and daily variation of Aspergillus Mich. ex Fr. spores in the atmophere of Cordoba (Spain). Allergol Immunopathol (Madr) 1990; 18: 167-173.
10. Beaumont F, Kauffman HF, Van-der Mark TH, Sluiter HJ, De Vries K. Volumetric aerobiological survey of conidial fungi in the north-east Netherlands. I. Seasonal patterns and the influence of metereological variables. Allergy 1985; 40: 173-180.
11. Mullins J, Hutcheson PS, Slavin RG. Aspergillus fumigatus spore concentration in the outside air: Cardiff and St. Louis compared. Clin Allergy 1984; 14: 351-354.
12. Cabnes FJ, Abarca ML, Bragulat MR, et al. Seasonal study of the fungal biota of the fur of dogs. Mycopathologia 1996; 133: 1-7.
13. Economopoulou P, Laskaris G, Ferekidis E, Kanelis N. Rhinocerebral mucormycosis with severe oral lesions: A case report. J Oral Maxillofac Surg 1995; 53: 215-217.
14. Petrikkos G, Skiada A, Sambatakou H, et al. Mucormycosis: Ten-year experience at a tertiary-care center in Greece. Eur J Clin Microbiol Infect Dis 2003; 22: 753-756.
15. Onerci M, Gursel B, Hosal S, Gulekon N, Gokoz A. Rhinocerebral mucormycosis with extension to the cavernous sinus. A case report. Rhinology 1991; 29: 321-324.
16. Saltoglu N, Tasova Y, Zorludemir S, Dundar IH. Rhinocerbral zygormycosis treated with liposomal amphotericin B and surgery. Mycoses 1998; 41: 45-49.
17. Bentur Y, Shupak A, Ramon Y, et al. Hyperbaric oxygen therapy for cutaneous soft tissue zygomycosis complicating diabetes mellitus. Plast Reconstr Surg 1998; 102: 822-824.
18. Moses AE, Rahav G, Barenholz Y, et al. Rhinocerebral mucormycosis treated with amphotericin B colloidal despersion in three patients. Clin Infect Dis 1998; 26: 1430-1433.
19. Linder N, Keller N, Hury C, Kuint J, Goldshmidt-Reuven A, Barzilai A. Primary cutaneous mucormycosis in a premature infant: Case report and review of the literature. Am J Perinatol 1998; 15: 35-38.
20. Morduchowicz G, Shmueli D, Shapira Z, et al. Rhinocerebral mucormycosis in renal ransplant recipients: Report of three cases and review of the literature. Rev Infect Dis 1986; 8: 441-446.
21. Talmi YP, Goldschmied-Reouven A, Bakon M, et al. Rhino-orbital and rhino-orbito-cerebral mucormycosis. Otolaryngol Head Neck Surg 2002; 127: 22-31.
22. Radlow R, Alf EF. An alternate multinomial assessment of the accuracy of the chi-square test of goodness of fit. J Am Statist Assoc 1975; 70: 811-813.
23. Waldorf AR, Ruderman N, Diamond RD. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus. J Clin Invest 1984; 74: 150-160.
24. Larone DH. Medically important fungi - a guide to identification, 3rd edn. Washington, DC: ASM Press, 1995.